Plexus’ (PLXS) Buy Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC restated their buy rating on shares of Plexus (NASDAQ:PLXS) in a report released on Friday,Benzinga reports. The firm currently has a $310.00 target price on the technology company’s stock.

A number of other equities research analysts have also recently weighed in on the company. Stifel Nicolaus upped their price target on Plexus from $280.00 to $330.00 and gave the stock a “buy” rating in a report on Monday, June 22nd. Raymond James Financial reaffirmed an “outperform” rating and set a $275.00 price objective on shares of Plexus in a report on Thursday, April 30th. Sidoti upgraded Plexus from a “neutral” rating to a “buy” rating and set a $308.00 target price on the stock in a research report on Friday, July 31st. Wall Street Zen upgraded Plexus from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Finally, Weiss Ratings downgraded Plexus from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday. One research analyst has rated the stock with a Strong Buy rating and six have assigned a Buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $273.00.

Plexus Price Performance

Shares of NASDAQ PLXS opened at $267.41 on Friday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.72 and a current ratio of 1.49. Plexus has a one year low of $126.86 and a one year high of $307.06. The firm has a market capitalization of $7.16 billion, a P/E ratio of 39.44 and a beta of 0.90. The company’s fifty day moving average is $272.41 and its two-hundred day moving average is $240.31.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings results on Wednesday, July 29th. The technology company reported $2.32 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.13 by $0.19. The business had revenue of $1.30 billion during the quarter, compared to the consensus estimate of $1.23 billion. Plexus had a net margin of 4.03% and a return on equity of 12.46%. The business’s revenue was up 28.2% compared to the same quarter last year. During the same quarter last year, the firm posted $1.64 EPS. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. Analysts forecast that Plexus will post 7.11 EPS for the current fiscal year.

Insider Buying and Selling

In other Plexus news, Director Michael V. Schrock sold 4,000 shares of the firm’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $275.00, for a total transaction of $1,100,000.00. Following the completion of the transaction, the director owned 40,329 shares of the company’s stock, valued at approximately $11,090,475. This trade represents a 9.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Todd P. Kelsey sold 1,500 shares of the business’s stock in a transaction on Wednesday, May 20th. The stock was sold at an average price of $252.77, for a total value of $379,155.00. Following the completion of the transaction, the chief executive officer directly owned 72,388 shares of the company’s stock, valued at approximately $18,297,514.76. This trade represents a 2.03% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 9,510 shares of company stock worth $2,625,182 in the last ninety days. Insiders own 1.78% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in shares of Plexus during the second quarter worth about $32,000. Covestor Ltd lifted its stake in shares of Plexus by 207.7% during the fourth quarter. Covestor Ltd now owns 240 shares of the technology company’s stock valued at $35,000 after buying an additional 162 shares during the period. Kilter Group LLC purchased a new position in shares of Plexus during the second quarter valued at approximately $40,000. Allworth Financial LP boosted its position in Plexus by 20.8% during the fourth quarter. Allworth Financial LP now owns 302 shares of the technology company’s stock worth $44,000 after acquiring an additional 52 shares during the last quarter. Finally, Persistent Asset Partners Ltd purchased a new stake in Plexus in the 2nd quarter worth approximately $71,000. 94.45% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about Plexus

Here are the key news stories impacting Plexus this week:

• Positive Sentiment: Needham analyst David Williams reiterated a Buy rating and maintained a $310 price target, implying roughly 16% upside from the recently referenced share price. The analyst cited a stronger revenue outlook. Analyst reiterates Buy on Plexus as revenue outlook surges
• Positive Sentiment: Zacks Research upgraded Plexus from Hold to Strong Buy and sharply increased its EPS forecasts across fiscal 2026-2028. Estimates rose to $7.02 for fiscal 2026, $8.50 for fiscal 2027 and $9.42 for fiscal 2028, indicating expectations for accelerating profitability. Earnings estimates rising for Plexus
• Positive Sentiment: The company’s latest quarterly report showed EPS of $2.32 versus the $2.13 consensus estimate and revenue of $1.30 billion versus expectations of $1.23 billion. Revenue increased 28.2% year over year, while fourth-quarter guidance calls for EPS of $2.47 to $2.63.
• Positive Sentiment: Recent institutional activity was supportive, including new or expanded positions by BlackRock, Bank of New York Mellon and Victory Capital. Institutions and hedge funds collectively own approximately 94.45% of PLXS shares.
• Neutral Sentiment: Despite the bullish revisions, Plexus trades at a relatively elevated valuation, with a price-to-earnings ratio near 39. Consensus analyst coverage remains favorable overall, with an average rating of Buy and a consensus price target near $273.
• Negative Sentiment: Director Michael Schrock sold 4,000 shares for approximately $1.1 million, reducing his position by 9.02%. The transaction was conducted under a pre-arranged Rule 10b5-1 plan, which reduces its significance as a discretionary bearish signal. Plexus director sells stock

About Plexus

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.